99% Purity CAS 179324-69-7 Bortezomib API Bortezomib Powder Bortezomib

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Bortezomib
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Bortezomib
• Name: Bortezomib Powder
• Appearance: White or off-White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anti Tumor;Antineoplastic
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 179324-69-7
• Mf: C19h25bn4o4
• MW: 384.23700
• Melting Point: 122-124°c
• Density: 1.214
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

99% Purity CAS 179324-69-7 Bortezomib API Bortezomib Powder Bortezomib

Product Description

Product Details

Product name	Bortezomib
Cas number	179324-69-7
Apperance	White or off-white powder
MF	C19H25BN4O4
MW	384.23700

Bortezomib is a reversible inhibitor of the chymase-like activity of 26S protease in mammalian cells. In vitro tests demonstrated that bortezomib is cytotoxic to many types of cancer cells. Preclinical tumor models In vivo testing demonstrates that bortezomib delays tumor growth, including multiple myeloma. This product is used in the treatment of patients with multiple myeloma, the effectiveness is based on its efficiency.

Application&Function

Bortezomib, a modified dipeptidyl boronic acid, is a therapeutic proteasome inhibitors used for the treatment of cancers. It is indicated for the treatment of relapsed multiple myeloma and mantle cell lymphoma. It is capable of inhibiting the mammalian 26S proteasome, which is important in regulating the intracellular concentration of specific proteins to maintain homeostasis within cells. The disruption of 26S proteasome function disrupts normal cellular homeostasis, leading to cytotoxic effect on various kinds of cancer cells. 

Specification